Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tilray Inc buy melinda

Start price
€43.04
17.05.19 / 50%
Target price
€83.89
04.11.21
Performance (%)
-57.02%
End price
€18.50
26.03.21
Summary
This prediction ended on 26.03.21 with a price of €18.50. The BUY prediction by melinda for Tilray Inc performed very badly with a performance of -57.02%. melinda has 50% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y 3y
Tilray Inc -14.105% -14.105% -78.620% -
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

According to melinda what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) -57.02%
Target price 83.886
Change
Ends at 04.11.21

SecteurProduits pharmaceutiques



3h12 26 septembre 2018 - Par Tomi Kilgore 
Supreme Cannabis conclut, approuve et approuve Tilray évalué à environ 9,3 millions de dollars. Co. Inc. cannabis suprême, Au Canada basée, branche Que de 7Acres un mercredi accord Conclu d'Tilray Canada Avait Avec approvisionnement, magasin de Tilray Inc.  En vertu de l'article 12 mois le 1er octobre et Qui a Debute la DonT Estimation à 12 millions est la Valeur de dollars , vous cannabis 7Acres à Tilray Canada fournira les patients Verser de cannabis médical. "Nous sommes heureux de fournir des produits de 7ACRES aux États-Unis de la qualité bien connue et de la gamme de patients Verser Tilray du monde existant ENTIER Soutenir" et Déclare le directeur général de cannabis Suprêmes John Fowler.  Les actions suprêmes du cannabis DE 37 Progrès Ont% Au Cours des Trois Vevak Derniers clips FNB Que ALORS Horizons marijuana de l'Indice des Sciences de la Vie à 31% et le



métier
Logo Tilray Inc
Comme société tenue Fonctionne, ne pas les FILIALES à la consacre recherche, la culture, la transformation et la distribution de de du cannabis médical

lance Tilray, Inc. Dans Recherches,culture,production etdistribution du cannabis et cannabinoïdes médical.

Ses produits comprennent du cannabis séché et des extraits de cannabis.

La société a été créée le 24 janvier 2018 et son siège à Nanaimo, au Canada.

Nombre d'employés  : 245 personnes.





In the thread Trading Tilray Inc
Prediction Buy
Perf. (%) -57.02%
Target price 83.886
Change
Ends at 04.11.21

Buy beendet

Stopped prediction by melinda for Tilray Inc

buy
Tilray Inc

Start price
Target price
Perf. (%)
€2.96
15.01.23
€3.50
15.01.24
-40.36%
16.01.24

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€4.14
15.11.22
€6.00
15.11.23
-28.55%
15.01.23

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€7.23
06.04.22
€10.00
06.04.23
-42.73%
15.11.22

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€18.50
26.03.21
€28.00
26.03.22
-57.95%
28.03.22

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€115.92
27.09.18
€193.03
22.01.19
-43.40%
22.01.19

Could be worthwhile Investment >10% per year
Tilray Inc

Start price
Target price
Perf. (%)
€159.38
20.09.18
€135.30
25.09.18
-32.68%
25.09.18

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€109.72
13.09.18
€180.40
17.09.18
-2.82%
17.09.18

Could be worthwhile Investment >10% per year
buy
Tilray Inc

Start price
Target price
Perf. (%)
€75.06
05.09.18
€83.89
05.09.18
13.84%
05.09.18

Could be worthwhile Investment >10% per year